Quest Diagnostics director granted 1,142 RSUs
Quest Diagnostics director Timothy L. Main received an award of 1,142 shares of Common Stock in the form of restricted stock units on May 20, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Quest Diagnostics director Timothy L. Main received an award of 1,142 shares of Common Stock in the form of restricted stock units on May 20, 2026. The award was granted at $0.00 per share as part of his compensation and is classified as a grant or award acquisition. Following this transaction, his directly owned Common Stock holdings increased to 27,439 shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,142 | $0.00 | $0.00 |
Footnotes (1)
- F1. Represents an award of restricted stock units.
Key Figures
Key Terms
restricted stock units financial
Common Stock financial
Grant, award, or other acquisition financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Quest Diagnostics (DGX) report for Timothy L. Main?
Was the Quest Diagnostics (DGX) insider transaction a purchase or an award?
What type of security was granted in the Quest Diagnostics (DGX) Form 4 filing?
Did the Quest Diagnostics (DGX) Form 4 report any insider sales or disposals?
AI-generated analysis. How Rhea-AI works. Not financial advice.